Gene Morse, PharmD, is a tenured, SUNY Distinguished Professor in the School of Pharmacy and Pharmaceutical Sciences. Dr. Morse is  Director of the Center for Integrated Global Biomedical Sciences at the University at Buffalo and Co-Director of the SUNY Global Health Institute. Dr. Morse has been actively involved in drug development and translational research since the introduction of antiretrovirals for the HIV epidemic and currently has funded research programs through the US National Institute of Allergy and Infectious Diseases and the Fogarty International Center. Dr. Morse is director of the Drug Development Core for the University at Buffalo Clinical and Translational Research Institute. He has been actively involved in drug development research since the introduction of antiretrovirals for HIV in 1986. Currently, he has National Institute of Allergy and Infectious Diseases (NIAID) support for the UB AIDS Clinical Trials Group (ACTG) Pharmacology Specialty Laboratory and a contract for the HIV Clinical Pharmacology Quality Assurance Program.  The UB laboratory receives funding toward drug development research in HIV and hepatitis C virus (HCV) research and has gained an international reputation for its work in bioanalysis, pharmacokinetics, and pharmacogenomics.